Gan&Lee Pharmaceuticals. Posted 439.5 Million Yuan Net Loss in 2022

Gan&Lee Pharmaceuticals. (甘李药业股份有限公司) (603087.SH) reported a net loss of 439.5 million yuan in 2022, reversing a net profit of 1.5 billion yuan for the previous year.

Meanwhile, the company posted 1.7 billion yuan in revenue, down 52.6% year-on-year.

At the end of the reporting period, it had 10.6 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 9.6%.